Individuals Stopping Anti-Obesity Injections Put On Pounds at a Quadrupled Rate Compared to Those on Conventional Diets

New research reveals that patients who discontinue popular GLP-1 drugs like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise programs.

Research printed in a major medical journal shows that while overweight people can lose a large proportion of their total mass while on the medication, the weight comes back at an average rate of nearly a kilo each month after stopping.

"Individuals purchasing such medications should be informed of the potential of quick weight regain when the treatment is stopped," stated researcher Dr. Susan Jebb.

This pace of recovery implies a reversion to starting weight in about one and a half years.

Comparing Treatments

The research, which looked at 37 of studies involving thousands of patients, compared the effects of these new drugs with older methods.

The team point out that people who shed pounds through diet and exercise usually experience a slower creep back—approximately 100 grams monthly—post-intervention.

Explaining the Rapid Rebound

Doctors believe the way of the injections explains the heightened regain.

GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate hunger.

"Artificially providing the hormone levels several times higher than the body's typical production could lead to the body to generate a reduced amount of its endogenous GLP-1, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition expert.

"Stopping of this hormone supplement means hunger is uncontrolled, making excessive eating much more probable."

A Chronic Condition?

Medical guidelines suggest the injections for individuals with obesity-related medical conditions, accompanied by prescribed lifestyle changes.

Professionals argue that, considering the significant potential of weight regain, the therapy might need to be life-long.

This view is reinforced by pharmaceutical companies, who state that the results "highlight the long-term nature of excess weight," comparing it to managing diseases like hypertension.

Patient Testimonies

People who have stopped the jabs describe a powerful return of hunger.

"It felt as if a trigger activating and you're instantly extremely hungry," said one woman.

The struggle is compounded if individuals have not developed lasting lifestyle or habit modifications during therapy.

Widespread Use

Figures suggest that millions of adults in the UK have tried these injections in the past year, with desire remaining high.

• Use is more common among women than males.
• The middle-aged age group shows the highest usage rates.
• Many obtain the medications through private prescriptions rather than public health services.

In conclusion, researchers stress that while GLP-1 drugs are powerful tools for shedding pounds, they are not a standalone fix and lasting health benefits likely depends on ongoing behavioural support.